UK approves its second weight-loss pill while EU access lags – POLITICO
However, with the arrival of the first GLP-1 pill Wegovy (semaglutide) from Danish competitor Novo Nordisk — which launched in the U.S. and U.K. this year and is soon expected in some EU countries — demand for the more-convenient tablet is expected to rise. Novo Nordisk has been attempting to reach as many patients as possible […]
Continue Reading